Evidence map›Paper›PMID 36523660›Full record

ReviewCureus2022

Use of Nanocomposites in Bone Regeneration.

Neha Masne, Ratnakar Ambade, Kunal Bhugaonkar

Abstract readReview
In one paragraph

Review in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Neha MasneMedical School, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, Wardha, IND.
Ratnakar AmbadeOrthopaedics, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, Wardha, IND.
Kunal BhugaonkarMedical School, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, Wardha, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article examines the compositions of bone tissue grafting and presents tissue culture and engineering formally as an approach for orthopaedic surgery. We assessed articles on bone grafts, analyzed their properties, advantages, and restrictions, and delivered explanations on technologies, including bone-tissue engineering (BTE). Osteo graft materials range from real human bone autografts (self-grafts) to substitute materials that can be used as grafts. These can be used single-handedly or conjointly to improve bone healing and regeneration. Tissue engineering is a relatively newer and evolving alternative for reducing the challenges of bone grafts and improving the rehabilitation of bone fractures and defects. Shortly, the combination of scaffolds, healing factors, gene therapy, and, more recently, 3D printing of tissue-engineered constructs may yield new perceptions. Natural bone tissue has a nanocomposite structure that offers the right biological and physical characteristics. It is essential that the biomaterial resemble real bone tissue in order to regenerate bone tissue. Because they can offer the correct matrix environment, combine desirable biological features, and allow regulated, sequential distribution of numerous growth factors for the different phases of bone tissue regeneration, nanocomposites are the ideal alternative for bone tissue regeneration. This is because no single type of material can replicate the composition, structure, and characteristics of native bone. A relatively new class of materials called nanocomposite biomaterials combines a biopolymeric and biodegradable matrix structure with nanoscale fillers that are bioactive and easily resorbable. There are also some things to think about when using nanoparticles and nanocomposites as scaffolds in clinical settings for bone tissue engineering.

Indexed as

bone graftnanocompositesnanomedicineorthopaedicsregenerative medicinetissue engineering

Identifiers

PMID36523660
PMCPMC9744436

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.